These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 11851670)

  • 1. Detection of micrometastases in lymph nodes from patients with breast cancer.
    Branagan G; Hughes D; Jeffrey M; Crane-Robinson C; Perry PM
    Br J Surg; 2002 Jan; 89(1):86-9. PubMed ID: 11851670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients.
    Marchetti A; Buttitta F; Bertacca G; Zavaglia K; Bevilacqua G; Angelucci D; Viacava P; Naccarato A; Bonadio A; Barassi F; Felicioni L; Salvatore S; Mucilli F
    J Pathol; 2001 Sep; 195(2):186-90. PubMed ID: 11592097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RT-PCR for mammaglobin genes, MGB1 and MGB2, identifies breast cancer micrometastases in sentinel lymph nodes.
    Ouellette RJ; Richard D; Maïcas E
    Am J Clin Pathol; 2004 May; 121(5):637-43. PubMed ID: 15151203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.
    Nos C; Harding-MacKean C; Fréneaux P; Trie A; Falcou MC; Sastre-Garau X; Clough KB
    Br J Surg; 2003 Nov; 90(11):1354-60. PubMed ID: 14598414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients.
    Nissan A; Jager D; Roystacher M; Prus D; Peretz T; Eisenberg I; Freund HR; Scanlan M; Ritter G; Old LJ; Mitrani-Rosenbaum S
    Br J Cancer; 2006 Mar; 94(5):681-5. PubMed ID: 16495929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of breast cancer metastasis in sentinel lymph nodes using intra-operative real time GeneSearch BLN Assay in the operating room: results of the Cardiff study.
    Mansel RE; Goyal A; Douglas-Jones A; Woods V; Goyal S; Monypenny I; Sweetland H; Newcombe RG; Jasani B
    Breast Cancer Res Treat; 2009 Jun; 115(3):595-600. PubMed ID: 18716862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.
    Manca G; Romanini A; Pellegrino D; Borsò E; Rondini M; Orlandini C; Zucchi V; Pasqualetti F; Mariani G
    J Nucl Med; 2008 Nov; 49(11):1769-75. PubMed ID: 18927334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A validation study of a new molecular diagnostic assay: the Dartmouth-Hitchcock Medical Center experience with the GeneSearch BLN assay in breast sentinel lymph nodes.
    Tafe LJ; Schwab MC; Lefferts JA; Wells WA; Tsongalis GJ
    Exp Mol Pathol; 2010 Feb; 88(1):1-6. PubMed ID: 19840784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maturation of dendritic cells and T-cell responses in sentinel lymph nodes from patients with breast carcinoma.
    Matsuura K; Yamaguchi Y; Ueno H; Osaki A; Arihiro K; Toge T
    Cancer; 2006 Mar; 106(6):1227-36. PubMed ID: 16475148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical validation of a molecular assay for intra-operative detection of metastases in breast sentinel lymph nodes.
    Martin Martinez MD; Veys I; Majjaj S; Lespagnard L; Schobbens JC; Rouas G; Filippov V; Noterman D; Hertens D; Feoli F; Bourgeois P; Durbecq V; Larsimont D; Nogaret JM
    Eur J Surg Oncol; 2009 Apr; 35(4):387-92. PubMed ID: 18639429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification.
    Noguchi S; Aihara T; Motomura K; Inaji H; Imaoka S; Koyama H
    Am J Pathol; 1996 Feb; 148(2):649-56. PubMed ID: 8579127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription-reverse transcription concerted reaction and minimal residual disease in axillary sentinel nodes of breast cancer.
    Ishikawa T; Miyajima E; Sasaki T; Tanabe M; Matsumoto C; Nozawa A; Kawachi K; Fukuno Y; Takeda H; Hayashi T; Onaka S; Momiyama N; Ichikawa Y; Inui K; Shimada H
    Eur J Surg Oncol; 2007 May; 33(4):430-4. PubMed ID: 17101257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of reverse transcriptase-polymerase chain reaction screening for micrometastic disease in axillary lymph nodes of breast cancer patients.
    Lockett MA; Metcalf JS; Baron PL; O'Brien PH; Elliott BM; Robison JG; Cole DJ
    Am Surg; 1998 Jun; 64(6):539-43; discussion 543-4. PubMed ID: 9619175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sectioning and immunohistochemical staining of sentinel nodes in patients with breast cancer.
    Motomura K; Komoike Y; Inaji H; Hasegawa Y; Kasugai T; Noguchi S; Koyama H
    Br J Surg; 2002 Aug; 89(8):1032-4. PubMed ID: 12153631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additional reverse transcription-polymerase chain reaction of peripheral slices is not superior to analysis of the central slice in sentinel lymph nodes from melanoma patients.
    Blaheta HJ; Roeger S; Sotlar K; Schittek B; Breuninger H; Bueltmann B; Garbe C
    Br J Dermatol; 2004 Mar; 150(3):477-83. PubMed ID: 15030330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category.
    Gimbergues P; Dauplat MM; Cayre A; Durando X; Le Bouedec G; Finat-Duclos F; Portefaix G; Kwiatkowski F; Dauplat J; Penault-Llorca F; Tchirkov A
    Eur J Surg Oncol; 2007 Feb; 33(1):16-22. PubMed ID: 17071045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of an extensive histopathologic examination and a real-time reverse-transcription-polymerase chain reaction assay for mammaglobin and cytokeratin 19 on axillary sentinel lymph nodes of breast carcinoma patients.
    Viale G; Dell'Orto P; Biasi MO; Stufano V; De Brito Lima LN; Paganelli G; Maisonneuve P; Vargo JM; Green G; Cao W; Swijter A; Mazzarol G
    Ann Surg; 2008 Jan; 247(1):136-42. PubMed ID: 18156933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based medicine applied to sentinel lymph node biopsy in patients with breast cancer.
    Barone JE; Tucker JB; Perez JM; Odom SR; Ghevariya V
    Am Surg; 2005 Jan; 71(1):66-70. PubMed ID: 15757061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Removal of two sentinel nodes accurately stages the axilla in breast cancer.
    Kennedy RJ; Kollias J; Gill PG; Bochner M; Coventry BJ; Farshid G
    Br J Surg; 2003 Nov; 90(11):1349-53. PubMed ID: 14598413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.